Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Dicrotophos |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01050
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Pesticide/Insecticide |
DME Modulation |
Dicrotophos up-regulates the expression of DME MAT2A |
[1] |
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01119
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the expression of DME MAT2A |
[2] |
2-butenal |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01122
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
2-butenal inhibits the expression of DME MAT2A |
[3] |
Chloropicrin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01247
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Chloropicrin inhibits the expression of DME MAT2A |
[4] |
Formaldehyde |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Formaldehyde inhibits the expression of DME MAT2A |
[5], [6] |
Nickel chloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01397
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Nickel chloride inhibits the expression of DME MAT2A |
[7] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME MAT2A |
[8], [9] |
Ethyl methanesulfonate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00772
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Ethyl methanesulfonate inhibits the expression of DME MAT2A |
[6] |
Aflatoxin B1 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 up-regulates the expression of DME MAT2A |
[10] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Acetaldehyde |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00872
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Acetaldehyde inhibits the expression of DME MAT2A |
[11] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Quercitrin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01449
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Quercitrin induces the drug-metabolizing activity of DME MAT2A |
[12] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 11 Xenobiotics
|
Cisplatin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin inhibits the expression of DME MAT2A |
[13] |
Copper sulfate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate up-regulates the expression of DME MAT2A |
[14] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME MAT2A |
[15] |
Dexamethasone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00088
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Dexamethasone up-regulates the expression of DME MAT2A |
[16] |
Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME MAT2A |
[17] |
Estradiol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Estradiol up-regulates the expression of DME MAT2A |
[18], [19] |
Fenofibrate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00035
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Fenofibrate inhibits the expression of DME MAT2A |
[20] |
Folic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00404
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Folic acid up-regulates the expression of DME MAT2A |
[16] |
Leflunomide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00053
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Leflunomide inhibits the expression of DME MAT2A |
[21] |
Methotrexate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00366
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Methotrexate inhibits the expression of DME MAT2A |
[22] |
Tretinoin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Tretinoin inhibits the drug-metabolizing activity of DME MAT2A |
[23] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
4-phenylbutyric acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00584
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2/3 |
DME Modulation |
4-phenylbutyric acid inhibits the expression of DME MAT2A |
[24] |
Ethanol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00539
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Ethanol inhibits the expression of DME MAT2A |
[25] |
MeIQx |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00609
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
MeIQx up-regulates the expression of DME MAT2A |
[2] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
(+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
(+)-JQ1 inhibits the expression of DME MAT2A |
[26] |
|
|
|
|
|
|